.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Key Updates in Melanoma from ESMO 2020

EP. 1: Molecular Testing in Stage III Melanoma

October 12th 2020

EP. 2: COMBI-AD Trial 5-Year Analysis Data

October 12th 2020

EP. 3: Checkpoint Blockade Trial Data Updates

October 12th 2020

EP. 4: KEYNOTE-054 and CheckMate 238 Trial Updates

October 12th 2020

EP. 5: Ipilimumab Dosing Significance in Adjuvant Setting

October 12th 2020

EP. 6: COMBI-i Trial Data Updates

October 12th 2020

EP. 7: Triple Therapy for the Management of Melanoma

October 12th 2020

EP. 8: Immune Checkpoint Inhibition in Stage IV Melanoma

October 12th 2020